News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Results from a recent RECOVER study suggest that adults who have COVID-19 may be more likely to develop a related condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Data provided by more than 3,800 new study participants reinforce how the long-term effects of COVID-19 can be different for everyone.
In 2024, RECOVER continued to advance scientific understanding of Long COVID through observational studies, clinical trials, and community engagement.
Editorial by NIH leaders shares how RECOVER has worked and will continue working to ease the suffering of those living with Long COVID.
The $662 million in funds received in 2024 will ensure that researchers can continue making progress toward understanding, diagnosing, preventing, and treating Long COVID through 2029.
Researchers can learn how to access and use data from RECOVER’s pediatric observational study during the next BioData Catalyst® (BDC) Community Hours event, scheduled for Tuesday, December 3rd, 2024, at 1:00 pm EST.
Findings from RECOVER’s pediatric observational study are an important first step toward including children in Long COVID clinical trials.
Recent findings from across RECOVER’s five research areas could improve our ability to identify people with Long COVID, understand the underlying causes of their symptoms, and provide them with care and treatment.